BMV:IBB Holdings Information

BMV:IBB is an equity ETF with a total of 249 individual holdings. The top holdings are Gilead Sciences stock at 8.29%, Vertex Pharmaceuticals at 7.56%, Amgen at 7.37%, Regeneron Pharmaceuticals at 5.64%, and Moderna at 4.50%.

Total Holdings

249

Top 10 Percentage

48.38%

Asset Class

Equity

ETF Category

Health Care

Assets

182.21B

PE Ratio

25.20

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	8.29%	5,793,029
2	VRTX	Vertex Pharmaceuticals Incorporated	7.56%	1,556,224
3	AMGN	Amgen Inc.	7.37%	1,970,848
4	REGN	Regeneron Pharmaceuticals, Inc.	5.64%	743,141
5	MRNA	Moderna, Inc.	4.50%	2,739,345
6	ARGX	argenx SE	3.92%	416,748
7	NTRA	Natera, Inc.	3.56%	1,009,534
8	RVMD	Revolution Medicines, Inc.	2.65%	1,445,631
9	ILMN	Illumina, Inc.	2.56%	1,129,288
10	ALNY	Alnylam Pharmaceuticals, Inc.	2.32%	1,000,201
11	BIIB	Biogen Inc.	2.29%	1,099,691
12	ONC	BeOne Medicines AG	2.19%	630,869
13	INSM	Insmed Incorporated	1.86%	1,613,113
14	INCY	Incyte Corporation	1.79%	1,506,822
15	UTHR	United Therapeutics Corporation	1.46%	310,886
16	ROIV	Roivant Sciences Ltd.	1.46%	3,930,488
17	GMAB	Genmab A/S	1.37%	4,154,438
18	ASND	Ascendis Pharma A/S	1.04%	462,359
19	NBIX	Neurocrine Biosciences, Inc.	1.03%	753,603
20	MEDP	Medpace Holdings, Inc.	1.00%	168,513
21	EXEL	Exelixis, Inc.	0.98%	1,799,054
22	CRL	Charles River Laboratories International, Inc.	0.94%	354,023
23	HALO	Halozyme Therapeutics, Inc.	0.89%	842,037
24	BMRN	BioMarin Pharmaceutical Inc.	0.87%	1,432,832
25	BBIO	BridgeBio Pharma, Inc.	0.83%	1,313,378

Showing 25 of 249 holdings

Subscribe to see the full list

Activate Now

As of Sep 21, 2026